Drug Delivery & Bio-Conjugation

This feed describes how bioconjugation, a covalent linking between the drug molecule and a biomolecule, can alter (facilitate or impede) drug delivery in living organisms. Discover the latest research on bioconjugation in drug delivery here

January 21, 2022

Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime and Amoxicillin during Pregnancy using bottom-up Physiologically based Pharmacokinetic Models.

Drug Metabolism and Disposition : the Biological Fate of Chemicals
Khaled AbduljalilMasoud Jamei
January 21, 2022
Review

Expanding the Reach of Precision Oncology by Drugging All KRAS Mutants.

Cancer Discovery
Marco H HofmannNorbert Kraut
January 21, 2022
Review

COVID-19 status quo: Emphasis on gastrointestinal and liver manifestations.

World Journal of Gastroenterology : WJG
Abhishek BhurwalVinod K Rustgi
January 21, 2022

Exploring a Novel Fasudil-Phospholipid Complex Formulated as Liposomal Thermosensitive in situ Gel for Glaucoma.

International Journal of Nanomedicine
Aya M KhallafNawal M Khalafallah
January 21, 2022
Open Access

Kidney-Targeted Redox Scavenger Therapy Prevents Cisplatin-Induced Acute Kidney Injury.

Frontiers in Pharmacology
Ryan M WilliamsDaniel A Heller
January 21, 2022
Review
Open Access

Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers.

Frontiers in Pharmacology
Luying HeWen Tan
January 21, 2022
Review
Open Access

Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed.

Frontiers in Microbiology
Xiaolan WuYan Liu
January 21, 2022
Review
Open Access

In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine.

Frontiers in Medical Technology
Alberto Williams-MedinaDamir Janigro
January 21, 2022
Review
Open Access

Exploring Dendrimer Nanoparticles for Chronic Wound Healing.

Frontiers in Medical Technology
Samuel Tetteh-QuarshieCynthia B Jones
January 21, 2022
Review

Targeting Non-coding RNA for Glioblastoma Therapy: The Challenge of Overcomes the Blood-Brain Barrier.

Frontiers in Medical Technology
Rohit K SharmaPablo E Vivas-Mejia
January 21, 2022
Review

Nanohybrids as Protein-Polymer Conjugate Multimodal Therapeutics.

Frontiers in Medical Technology
Pallavi KiranRohit Srivastava
January 21, 2022
Open Access

The Development of an ex vivo Flow System to Assess Acute Arterial Drug Retention of Cardiovascular Intravascular Devices.

Frontiers in Medical Technology
Kathryn CooperSaami K Yazdani
January 21, 2022
Review
Open Access

Calcium Phosphate-Based Bioceramics in the Treatment of Osteosarcoma: Drug Delivery Composites and Magnetic Hyperthermia Agents.

Frontiers in Medical Technology
Tiê Menezes OliveiraLucas Freitas Berti
January 21, 2022
Review

Prospects of microbial polysaccharides-based hybrid constructs for biomimicking applications.

Journal of Basic Microbiology
Sarmad Ahmad QamarBo-Zhong Mu

Sign up to follow this feed and discover related papers.

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2022 Meta ULC. All rights reserved
/feed-previews/drug-delivery-bio-conjugation/b0724bd7-b07d-45f6-a4ce-1c405c068111